Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammatory Bowel Diseases × Oxygen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Lung Neoplasms 3 Anxiety Disorders 3 Solitary Pulmonary Nodule 2 Paresthesia 2 Multiple Pulmonary Nodules 2 Hypesthesia 2 Dyspnea 2 Depression 2 Brain Neoplasms 2 Surgical Wound Infection 1 Skin Neoplasms 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Prostatic Diseases 1 Postoperative Complications 1 Pain 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Inflammatory Bowel Diseases 1 Hypoxia 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Tea 3 Polyethylene Glycols 3 Infliximab 3 MEDI2070 2 Lidocaine 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 sodium phosphate 1 prucalopride 1 polyethylene glycol 400 1 picosulfate sodium 1 golimumab 1 cabozantinib 1 Surgical Tape 1 Standard of Care 1 Spectrum Analysis, Raman 1 Specimen Handling 1 Pneumococcal Vaccines 1 Platinum Compounds 1 Passive Cutaneous Anaphylaxis 1 Papillomavirus Vaccines 1 Oxygen 1 Nivolumab 1 Neomycin 1 Narrow Band Imaging 1 Morphine 1 Metronidazole 1 Medical Marijuana 1 Laparoscopy 1 Ipilimumab 1 Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06109961 2023-11-07

HYPNOTIC

Ottawa Hospital Research Institute

Phase 1/2 Unknown

Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡